Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.

Laurent Servais21 enrolled

Overview

ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. We plan to include a group of approximately 20 patients with MS. This study include a unique evaluation in the laboratory of analysis of human movement. A set of tasks will be performed by patients wearing of two magneto-inertial sensors.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Multiple Sclerosis

Interventions

Actimyo°DEVICE

Actimyo° is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.

IMUDEVICE

IMU is a portable system of miniaturized inertial sensors for objective, instrumental, ambulatory, and validated analysis of normal and pathological human gait. Each miniaturized inertial sensor (2 cm × 0.7 cm × 0.5 cm) includes a triaxial accelerometer and a triaxial gyroscope. These four inertial sensors are connected to a box by wires and are numbered 1 to 4. They must be attached - using adhesive tapes - on the participant's shoes.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed MS diagnosis, * Over 18 years old, * Ambulant patients, * Signed informed consent, * No clinical and / or radiological relapse within 3 months. Exclusion Criteria: * Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection. * Any other previous or present pathology having an impact on motor function. * Recent surgery or trauma (less than 6 months) in the upper or lower limbs

Locations (1)

Centre Hospitalier Régional de la Citadelle

Liège, Liège, Belgium

Outcomes

Primary Outcomes

95th centile of stride velocity

95th centile of stride velocity obtained with magneto-inertial sensors and a motion capture device (meter/second).

Time frame: One day

50th centile of stride velocity

50th centile of stride velocity obtained with magneto-inertial sensors and a motion capture device (meter/second).

Time frame: One day

95th centile of stride length

95th centile of stride length obtained with magneto-inertial sensors and a motion capture device (meter).

Time frame: One day

50th centile of stride length

50th centile of stride length obtained with magneto-inertial sensors and a motion capture device (meter).

Time frame: One day

Stance phase time

Stance time over full stride time for each foot obtained with magneto-inertial sensors and a motion capture device (percentage).

Time frame: One day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.